NEW YORK (GenomeWeb) – Roswell Park Cancer Institute today said that the New York State Department of Health has granted approval for the institute to test cancer patients using its OmniSeq Target molecular diagnostic test.
Registering provides access to this and other free content.
Already have an account?Login Now.
Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.
In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.
South African researchers uncover bone cancer in an ancient hominin ancestor.
English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.